Literature DB >> 23923644

An alternative splice process renders the MLL protein either into a transcriptional activator or repressor.

T Rössler1, R Marschalek.   

Abstract

The biological process of differentiation - from a fertilized egg to a human being - is a consecutive mechanism that leads to the establishment of tissue-specific gene expression, but also to a coordinated shut-down of all those genes that are not necessary for a given cell type. This process is accompanied by posttranslational modifications of the chromatin (DNA methylation and covalent histone modifications), also termed the "epigenetic layer". All epigenetic processes are mediated by protein complexes that either mediate specific DNA methylation patterns, or modify nucleosomal proteins in a covalent fashion (acetylation, methylation, phosphorylation and ubiquitinylation). One important player involved in epigenetics is the MLL protein which represents a histone H3 methyltransferase. The MLL gene gained much attention because of its frequent genetic rearrangements, thereby creating oncogenic MLL fusion genes that cause acute leukemia in pediatric and adult patients. This article is summarizing certain functional aspects about MLL, but is mainly emphasizing on an alternative splice event within the PHD domain. This changes the biological properties of the MLL protein, thereby influencing its ability of being either a transcriptional activator or repressor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23923644     DOI: 10.1055/s-0033-1343653

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  11 in total

Review 1.  Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors:  Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

Review 2.  Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.

Authors:  Christina N Vallianatos; Shigeki Iwase
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

3.  Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL.

Authors:  K Ahmad; C Katryniok; B Scholz; J Merkens; D Löscher; R Marschalek; D Steinhilber
Journal:  Oncogenesis       Date:  2014-11-17       Impact factor: 7.485

4.  The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanism.

Authors:  Alessa Kühn; Denise Löscher; Rolf Marschalek
Journal:  Oncotarget       Date:  2016-06-07

5.  The MLL recombinome of acute leukemias in 2017.

Authors:  C Meyer; T Burmeister; D Gröger; G Tsaur; L Fechina; A Renneville; R Sutton; N C Venn; M Emerenciano; M S Pombo-de-Oliveira; C Barbieri Blunck; B Almeida Lopes; J Zuna; J Trka; P Ballerini; H Lapillonne; M De Braekeleer; G Cazzaniga; L Corral Abascal; V H J van der Velden; E Delabesse; T S Park; S H Oh; M L M Silva; T Lund-Aho; V Juvonen; A S Moore; O Heidenreich; J Vormoor; E Zerkalenkova; Y Olshanskaya; C Bueno; P Menendez; A Teigler-Schlegel; U Zur Stadt; J Lentes; G Göhring; A Kustanovich; O Aleinikova; B W Schäfer; S Kubetzko; H O Madsen; B Gruhn; X Duarte; P Gameiro; E Lippert; A Bidet; J M Cayuela; E Clappier; C N Alonso; C M Zwaan; M M van den Heuvel-Eibrink; S Izraeli; L Trakhtenbrot; P Archer; J Hancock; A Möricke; J Alten; M Schrappe; M Stanulla; S Strehl; A Attarbaschi; M Dworzak; O A Haas; R Panzer-Grümayer; L Sedék; T Szczepański; A Caye; L Suarez; H Cavé; R Marschalek
Journal:  Leukemia       Date:  2017-07-13       Impact factor: 11.528

Review 6.  Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors.

Authors:  Musaffe Tuna; Christopher I Amos; Gordon B Mills
Journal:  Oncotarget       Date:  2019-03-12

7.  Zinc and Its Transporters in Epigenetics.

Authors:  Sofia Brito; Mi-Gi Lee; Bum-Ho Bin; Jong-Soo Lee
Journal:  Mol Cells       Date:  2020-04-30       Impact factor: 5.034

8.  The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11).

Authors:  Alexander Wilhelm; Rolf Marschalek
Journal:  Oncogene       Date:  2021-09-06       Impact factor: 9.867

Review 9.  Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways.

Authors:  Rolf Marschalek
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

Review 10.  Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Oriol de Barrios; Maribel Parra
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.